Jerel Davis, PhD

Managing Director, Versant Ventures

Jerel is a Managing Director based at Versant Ventures. Since joining Versant in 2011, he has played a critical role in launching and investing in a number of Versant’s portfolio companies including Quanticel Pharmaceuticals, Crispr Therapeutics, Blueline Bioscience, Northern Biologics and several of the Inception Sciences discovery start-ups.

+ Show More

Todd Foley

Managing Director, MPM Capital

Todd is a Managing Director at MPM Capital. He focuses on biotech investments, and in addition to serving on Repare’s board, he serves on a number of MPM portfolio company boards, including Switch Bio, Chiasma (CHMA), ClinicalInk, Iconic, Rhythm, Semma and Tetherex.

+ Show More

Lloyd M. Segal

President & CEO, Repare Therapeutics

Lloyd is an Entrepreneur-in-residence at Versant Ventures, and from 2010-2016 was a Managing Partner at Persistence Capital Partners, a leading Healthcare private equity investor. He held CEO roles at Caprion Pharmaceticals, which he co-founded, Advanced Bioconcept and Thallion Pharmaceuticals, and has served as a director of several public and private corporations in the U.S. and Canada.

+ Show More